The primary outcome was CIN incidence, while secondary outcomes included, changes in serum creatinine, serum cystatin C, blood urea nitrogen (BUN), and estimated glomerular filtration rate (eGFR). The gene discussed is CST3; the disease is cervical squamous intraepithelial neoplasia.